Investigating the effects of patching therapy in children with congenital cataracts
Secondary Analyses of data from the Infant Aphakia Treatment Study: Patching in Children with Unilateral Congenital Cataracts and Poor Visual Acuity
This study looks at how well patching therapy works for kids with cataracts in one eye, focusing on how well families can stick to the patching schedule and whether the benefits are worth the costs, so we can give better advice on treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Mason University NIH-funded |
| Lab location | 1 site (Fairfax, United States) |
| Project ID | NIH-10557912 on NIH RePORTER |
What this research studies
This research focuses on children with unilateral congenital cataracts, a condition that can severely impact vision. It analyzes data from previous studies to understand the effectiveness of patching therapy, which involves covering the unaffected eye to encourage the use of the affected eye. The goal is to assess how well caregivers can adhere to patching schedules and to evaluate the costs versus benefits of extended patching in cases where the treated eye may not develop usable vision. By examining these factors, the research aims to provide clearer guidelines for treatment protocols.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with unilateral congenital cataracts who are undergoing patching therapy.
Not a fit: Patients with bilateral cataracts or those who have already achieved good visual acuity in the treated eye may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for children with congenital cataracts, enhancing their visual outcomes.
How similar studies have performed: Previous studies on patching therapy in pediatric ophthalmology have shown varying degrees of success, indicating that this area of research is both relevant and necessary.
Where this research is happening
Fairfax, United States
- George Mason University — Fairfax, United States (Active)
Researchers
- Principal investigator: Drews-Botsch, Carolyn Dawson — George Mason University
- Study coordinator: Drews-Botsch, Carolyn Dawson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.